The University of Southampton
University of Southampton Institutional Repository

Neuroprotection against excitotoxic cell damage in rat striatum and hippocampus

Neuroprotection against excitotoxic cell damage in rat striatum and hippocampus
Neuroprotection against excitotoxic cell damage in rat striatum and hippocampus

Injection of excitatory amino acid analogues into the rat striatium produced a marked loss of NADPH-diaphorase (NADPH-d), acetylcholinesterase (AChE) and cresyl violet stained cells. Cell counts for these markers showed approximately a 90% reduction. Injection of kainic acid and quinolinic acid into the rat hippocampus caused a complete loss of pyramidal cells (CAl-CA4) and granule cells of dentate gyrus. Intraventricular (icv) injection of kainic acid caused a selective loss of CA3/CA4 pyramidal cells. Co-injection of NMDA antagonists with quinolinic acid, NMDA, ibotenic acid and glutamic acid in the striatum and hippocampus led to a 80% neuroprotection. Co-injection of an equimolar concentration of AP7 with kainic acid produced neuroprotection in both regions. Lower concentrations of AP7, while able to protect against intrastriatal quinolinic acid toxicity, was unable to protect against kainic acid toxicity. Systemic injection of MK-801 protected against quinolinic acid but not kainic acid toxicity. Co-injection of 2-chloroadenosine (CLAD) and kainic acid produced a dose-dependent protection in rat striatum and hippocampus. This protection was partially reversed with theophylline. Co-injection of CLAD with quinolinic acid only produced a slight protection. Using continuous fluorometry, CLAD was shown to inhibit potassium-evoked endogenous glutamate release in crude synaptosomes and slices. Kainic acid (1mM) failed to promote a calcium-dependent release of endogenous glutamate from these preparations. Both Potassium and kainic acid enhanced the release of glutamate from guinea-pig purified cerebrocortical synaptosomes. CLAD inhibited this release in a manner sensitive to the A1-adenosine receptor antagonist 8-cyclopentyl-theophylline (CPT). CLAD reduced calcium entry into rat cortical synaptosomes loaded with the calcium indicator quin-2. This effect was reversed by theophylline. Kainic acid failed to enhance calcium influx in the same preparation. Purified cortical synaptosomes preloaded with quin-2, were exposed to barium ions in a calcium-free medium. Barium influx caused a rapid increase influorescence which was inhibited by CLAD. The selective A1 agonist cyclopentyladenosine was not as effective while the A2 agonist cyclopropyl-carboxamidoadenosine was ineffective.

University of Southampton
Arvin, Babak
Arvin, Babak

Arvin, Babak (1989) Neuroprotection against excitotoxic cell damage in rat striatum and hippocampus. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Injection of excitatory amino acid analogues into the rat striatium produced a marked loss of NADPH-diaphorase (NADPH-d), acetylcholinesterase (AChE) and cresyl violet stained cells. Cell counts for these markers showed approximately a 90% reduction. Injection of kainic acid and quinolinic acid into the rat hippocampus caused a complete loss of pyramidal cells (CAl-CA4) and granule cells of dentate gyrus. Intraventricular (icv) injection of kainic acid caused a selective loss of CA3/CA4 pyramidal cells. Co-injection of NMDA antagonists with quinolinic acid, NMDA, ibotenic acid and glutamic acid in the striatum and hippocampus led to a 80% neuroprotection. Co-injection of an equimolar concentration of AP7 with kainic acid produced neuroprotection in both regions. Lower concentrations of AP7, while able to protect against intrastriatal quinolinic acid toxicity, was unable to protect against kainic acid toxicity. Systemic injection of MK-801 protected against quinolinic acid but not kainic acid toxicity. Co-injection of 2-chloroadenosine (CLAD) and kainic acid produced a dose-dependent protection in rat striatum and hippocampus. This protection was partially reversed with theophylline. Co-injection of CLAD with quinolinic acid only produced a slight protection. Using continuous fluorometry, CLAD was shown to inhibit potassium-evoked endogenous glutamate release in crude synaptosomes and slices. Kainic acid (1mM) failed to promote a calcium-dependent release of endogenous glutamate from these preparations. Both Potassium and kainic acid enhanced the release of glutamate from guinea-pig purified cerebrocortical synaptosomes. CLAD inhibited this release in a manner sensitive to the A1-adenosine receptor antagonist 8-cyclopentyl-theophylline (CPT). CLAD reduced calcium entry into rat cortical synaptosomes loaded with the calcium indicator quin-2. This effect was reversed by theophylline. Kainic acid failed to enhance calcium influx in the same preparation. Purified cortical synaptosomes preloaded with quin-2, were exposed to barium ions in a calcium-free medium. Barium influx caused a rapid increase influorescence which was inhibited by CLAD. The selective A1 agonist cyclopentyladenosine was not as effective while the A2 agonist cyclopropyl-carboxamidoadenosine was ineffective.

This record has no associated files available for download.

More information

Published date: 1989

Identifiers

Local EPrints ID: 458282
URI: http://eprints.soton.ac.uk/id/eprint/458282
PURE UUID: 74fb7714-7459-45eb-bde8-94f295ce33bb

Catalogue record

Date deposited: 04 Jul 2022 16:46
Last modified: 04 Jul 2022 16:46

Export record

Contributors

Author: Babak Arvin

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×